Nuo Therapeutics, Inc. (AURX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$1.14M

Year ended 2025-12-31

-$2.45M

Trailing 12 months to 2026-06-30

2010-12-31 Free Cash Flow (USD) 2025-12-31

Period ended	Free Cash Flow	Change YoY	Source filing
2025-12-31	-$1.14M	n/m	2026-03-30, From 2025-01-01
2024-12-31	-$2.39M	n/m	2026-03-30, From 2024-01-01
2023-12-31	-$3.18M	n/m	2025-04-01, From 2023-01-01
2022-12-31	-$3.77M	n/m	2024-04-19, From 2022-01-01
2021-12-31	-$120.0K	n/m	2023-04-17, From 2021-01-01
2020-12-31	-$53.8K	n/m	2022-04-15, From 2020-01-01
2019-12-31	-$921.7K	n/a	2022-04-15, From 2019-01-01
No annual figure between 2015-12-31 and 2019-12-31.
2015-12-31	-$15.09M	n/m	2016-10-24, From 2015-01-01
2014-12-31	-$17.91M	n/m	2016-10-24, From 2014-01-01
2013-12-31	-$12.15M	n/a	2015-03-31, From 2013-01-01
No annual figure between 2011-12-31 and 2013-12-31.
2011-12-31	-$4.31M	n/m	2013-03-18, From 2011-01-01
2010-12-31	-$4.31M	n/a	2012-03-29, From 2010-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Free Cash Flow	Change YoY
Nuo Therapeutics, Inc. (AURX)	2025-12-31	-$1.14M	n/m
IceCure Medical Ltd. (ICCM)	2025-12-31	-$14.61M	n/m
Tenon Medical, Inc. (TNON)	2025-12-31	-$11.02M	n/m
Intelligent Bio Solutions Inc. (INBS)	2026-06-30	-$12.05M	n/m
Lucid Diagnostics Inc. (LUCD)	2025-12-31	-$46.68M	n/m
Femasys Inc (FEMY)	2025-12-31	-$19.22M	n/m
Cerenome, Inc. (CNSY)	2025-12-31	-$20.84M	n/m
Vycor Medical Inc (VYCO)	2025-12-31	-$18.7K	n/m
EBR Systems, Inc. (NONE.)	2025-12-31	-$56.88M	n/m

Compare AURX, ICCM, TNON, INBS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗